Throat swabs in children with respiratory tract infection:associations with clinical presentation, and potential targets for point-of-care testing by Thornton, Hannah et al.
                          Thornton, H., Hay, A., Redmond, N., Turnbull, S., Christensen, H., Peters, T.
J., ... Blair, P. (2017). Throat swabs in children with respiratory tract
infection: associations with clinical presentation, and potential targets for
point-of-care testing. Family Practice. DOI: 10.1093/fampra/cmw136
Publisher's PDF, also known as Version of record
License (if available):
CC BY-NC
Link to published version (if available):
10.1093/fampra/cmw136
Link to publication record in Explore Bristol Research
PDF-document
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
© The Author 2017. Published by Oxford University Press.  1
Family Practice, 2017, 1–9
doi:10.1093/fampra/cmw136
Epidemiology
Throat swabs in children with respiratory tract 
infection: associations with clinical presentation 
and potential targets for point-of-care testing
Hannah V Thorntona,*, Alastair D Haya, Niamh M Redmonda,b,  
Sophie L Turnbulla, Hannah Christensenc, Tim J Petersd, John P Leeminge, 
Andrew Loveringe, Barry Vipondf, Peter Muirf and Peter S Blairc 
aCentre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, 
UK, bNational Institute for Health Research Collaborations for Leadership in Applied Health Research and Care 
West (NIHR CLAHRC West), University Hospitals Bristol NHS Foundation Trust, Bristol, UK, cSchool of Social and 
Community Medicine, University of Bristol, Bristol, UK, dSchool of Clinical Sciences, University of Bristol, Bristol, UK, 
eInfection Sciences, North Bristol NHS Trust, Bristol, UK and fPublic Health Laboratory Bristol, National Infection 
Service, Public Health England, Bristol, UK.
*Correspondence to Hannah V. Thornton, Centre for Academic Primary Care, School of Social and Community Medicine, 
University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK; E-mail: hannah.thornton@bristol.ac.uk
Abstract
Background and objectives. Diagnostic uncertainty over respiratory tract infections (RTIs) in 
primary care contributes to over-prescribing of antibiotics and drives antibiotic resistance. 
If symptoms and signs predict respiratory tract microbiology, they could help clinicians target 
antibiotics to bacterial infection. This study aimed to determine relationships between symptoms 
and signs in children presenting to primary care and microbes from throat swabs.
Methods. Cross-sectional study of children ≥3 months to <16 years presenting with acute cough 
and RTI, with subset follow-up. Associations and area under receiver operating curve (AUROC) 
statistics sought between clinical presentation and baseline microbe detection. Microbe prevalence 
compared between baseline (symptomatic) and follow-up (asymptomatic) visits.
Results. At baseline, ≥1 bacteria was detected in 1257/2113 (59.5%) children and ≥1 virus in 894/2127 
(42%) children. Clinical presentation was not associated with detection of ≥1 bacteria [AUROC 0.54 
(95% CI 0.52–0.56)] or ≥1 virus [0.64 (95% CI 0.61–0.66)]. Individually, only respiratory syncytial 
virus (RSV) was associated with clinical presentation [AUROC 0.80 (0.77–0.84)]. Prevalence fell 
between baseline and follow-up; more so in viruses (68% versus 26%, P < 0.001) than bacteria (56% 
versus 40%, P = 0.01); greatest reductions seen in RSV, influenza B and Haemophilus influenzae.
Conclusion. Findings demonstrate that clinical presentation cannot distinguish the presence 
of bacteria or viruses in the upper respiratory tract. However, individual and overall microbe 
prevalence was greater when children were unwell than when well, providing some evidence 
that upper respiratory tract microbes may be the cause or consequence of the illness. If causal, 
selective microbial point-of-care testing could be beneficial.
Key words:  Bronchitis, common cold, diagnostic tests, laboratory, pediatrics, primary care, ultrasound, upper respiratory 
infections.
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Introduction
Respiratory tract infections (RTIs) are considered the ‘bread and 
butter’ of primary care by clinicians across the globe (1–3). Of all 
paediatric visits for RTI, acute cough is the most common com-
plaint, accounting for up to 75% of visits (4,5). Despite this, most 
RTIs are self-limiting. A 2008 review by the UK’s National Institute 
of Health and Care Excellence (NICE) concluded that antibiotics 
do not confer a clinically significant reduction in the time taken to 
recover from an RTI. NICE guidelines recommend that antibiotics 
are not prescribed for the majority of paediatric RTIs (3), and in 
doing so are consistent with the 2011 European Respiratory Society 
adult prescribing guidelines (6). However, antibiotic prescribing 
rates remain high (7).
The decision to prescribe antibiotics in primary care is complex 
and mediated by clinical and non-clinical factors (8,9). For clini-
cians, well-described diagnostic uncertainty exists between the pres-
entation of acute cough, and the appropriate management. A recent 
systematic review (10) reported an absence of evidence as to whether 
information available to primary care clinicians at the point of care, 
namely the findings from the clinical history and examination, can 
be used to diagnose bacterial or viral infection.
This study aimed to define the sensitivity and specificity of clini-
cal symptoms and signs in identifying bacterial or viral detection 
from the throat of children presenting to primary care with acute 
cough. A follow-up study investigated the use of throat swabs as a 
diagnostic tool by comparing viral and bacterial detection between 
children when they were unwell with RTI, and when they had 
recovered.
Materials and methods
Study design and population
Primarily a cross-sectional study, with a small follow-up study pro-
viding repeated measures for a nested sub-sample of children. Data 
for the cross-sectional study were collected at baseline primary care 
consultations as part of the ‘TARGET’ cohort study, which recruited 
children aged three months to 16 years presenting to primary care 
with acute cough and RTI between July 2011 and June 2013 (11). 
Primary care practices were recruited via study centres in London, 
Oxford, Bristol and Southampton, UK. Microbiological samples 
were collected only at the Bristol centre, primarily from children in 
the South West of England, and the data from these Bristol centre 
children only are included in these analyses.
Clinical data collection
Clinicians completed baseline case report forms for all participants 
at recruitment recording sociodemographic information, presence 
and severity of RTI-related symptoms and signs, working diagnosis 
and antibiotic prescribing decision (Supplementary Data Table S1). 
Clinicians sought to take throat swabs from all Bristol centre chil-
dren, and all families were asked to complete online or paper ‘symp-
tom diaries’ recording presence of six key symptoms for 28  days 
following recruitment. The 2007 Indices of Multiple Deprivation 
(IMD) score, linked to the child’s home address, was used as a proxy 
for home deprivation.
Bristol children were invited by post to the follow-up study, and 
visited again at home by a researcher once the symptom diary record 
indicated recovery. Repeated clinical data and throat swabs were 
collected. Only children who were not prescribed antibiotics at the 
baseline visit were recruited to the follow-up study.
Microbiological sampling
Throat samples were obtained by sweeping a dual polyurethane 
foam tipped swab (Medical Wire and Equipment, Corsham, UK) 
across the mucus membranes of the posterior oropharynx in the 
region of the pharyngopalatine arch; both tips of the swab touched 
both sides of the throat. The two swab tips were snapped off and 
sealed into separate plastic specimen vials containing transport 
medium. Vials were transported either using a first class Post Office 
Safebox™ or via existing same-day hospital transport (for prac-
tices in the Bristol city area) to the Bristol Centre for Antimicrobial 
Research and Evaluation (BCARE) at Southmead Hospital, Bristol, 
UK. The bacterial culture laboratory processed one vial, and sent the 
second to the viral identification laboratory by hospital courier for 
identification of viruses and additional bacteria by semi-quantitative 
real time polymerase chain reaction (qPCR).
Microbe identification
A total of 12 RTI-related bacteria and 14 RTI-related viruses were 
sought from all throat swabs. Standard laboratory methods (either 
bacterial culture or qPCR) were used to identify each microbe. 
Microbes sought, and detection methods used, are described in detail 
elsewhere (11) and summarized in Table 1.
Statistical analyses
In the cross-sectional study, we sought associations between microbes 
detected from throat swabs at the baseline consultation, and pres-
ence and severity of symptoms and signs at the baseline consultation.
Designated outcome variables were the detection of individual or 
groups of microbes: (i) ≥1 type of RTI-related bacterium, (ii) ≥1 type 
of RTI-related virus and (iii) single named microbes (where baseline 
prevalence was ≥5%). Explanatory variables considered were clini-
cal symptom and sign data, socio-demographic data, seasonality and 
sample transport time.
We used univariable and multivariable logistic regression 
models to examine predictive values of symptoms and signs for 
microbe detection, adjusted for demographic variables. Those 
associated (P  <  0.01) with detection of RTI-related microbes in 
univariable analysis were entered into multivariable models. 
Manual backward stepwise binary logistic regression was used 
to obtain adjusted ORs for microbe detection in the presence of 
symptoms and signs.
Discrimination of each regression model was measured using the 
area under the Receiver Operating Characteristic (AUROC) curve 
and its 95% CI. Interactions between explanatory variables in mul-
tivariable models were also explored, and further investigated where 
p-values for the relevant interaction odds ratios were <0.05.
In the follow-up study, we compared detection rates of (i) ≥1RTI-
related bacteria and (ii) ≥1RTI-related virus between samples taken 
at baseline (symptomatic) and follow-up (asymptomatic) consulta-
tions. We also compared detection rates of individual microbes at 
each visit (microbes with baseline consultation prevalence ≥5% 
only). A Bonferroni correction was applied due to multiple compari-
sons, with resultant test-wise significance level of 0.005. Analysis 
was conducted in STATA v14 (StataCorp. 2015).
Results
Ascertainment
Recruitment to the cross-sectional and follow-up studies is detailed 
in Figure 1.
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Cross-sectional study
Population characteristics
The median age of the 2296 children recruited to the cross-sectional 
study was 3 years [interquartile range (IQR) 1–6], with 760 (33%) 
aged <12 months. There were 1188 (52%) males, with 2018 (88%) 
reporting ethnicity as white British (similar to UK Census 2011 
data) (12). Median maternal age at child’s birth was 30 years (IQR 
26–34), and 466 (21%) mothers were smokers (similar to national 
data) (13).
The most common symptoms reported were disturbed sleep, pre-
sent in 78% of cases, and blocked or runny nose, present in 77%. 
Antibiotics were immediately prescribed to 745 (32%) children, and 
delayed prescriptions issued to a further 189 (8%).
Microbe prevalence in cross-sectional study population
In total, ≥1 type of study bacterium was detected in 1257/2113 
(59.5%) of samples; ≥1 type of study virus was detected in 894/2127 
(42.0%) of samples. There were 672 (32%) swabs positive for at least 
one type of study bacteria in the absence of any virus; 305 (14%) 
were positive for at least one type of study virus in the absence of 
any bacteria; 583 (28%) were positive for both a study bacteria and 
a study virus; and 549 (26%) swabs had no study microbes detected.
Individual microbe prevalence in the cross-sectional 
study sample
The prevalence of individual microbes detected from study throat 
swabs is presented in Table  1. The most prevalent bacterium was 
Staphylococcus aureus (detected in 33% of samples), followed 
by H.  influenzae (24%), Streptococcus pneumoniae (15%) and β 
haemolytic Streptococcus A (8%). The most prevalent viruses were 
rhinoviruses (detected in 13% of samples), followed by enteroviruses 
(7%), respiratory syncytial virus (RSV; 6%) and influenza A (4.4%). 
Enteroviruses and rhinoviruses are genetically similar and some 
strains may be detected by both rhinovirus and enterovirus PCR 
tests. However of 407 patients in whom positive results were found 
with enterovirus and/or rhinovirus assays, only 17 (4.2%) tested 
positive using both assays. It is not possible to determine if these 
results represent assay cross-reactivity or dual infection. However 
for the purposes of this study we considered these 17 samples to 
represent dual rhinovirus/enterovirus infections.
Predictors of microbe detection: detection of any bacteria
Of all demographic characteristics and symptoms and signs col-
lected (full list in Supplementary Data Table S1), 14 were associated 
with the detection of ≥1 type of bacterium in univariable analysis 
(Supplementary Data Table S2). However, in multivariable analysis, 
only one variable remained associated with the detection of bacte-
ria: low energy during the illness (Table 2). The model showed poor 
discrimination, with AUROC of 0.54 [95% CI 0.52–0.56]. Bacterial 
detection was not associated with clinician-reported diagnosis of 
bacterial infection: in 119 children for whom clinicians reported 
specific suspicion of bacterial cause, 54% had RTI-related bacteria 
detected from their throat swab, versus 60% with no bacterial cause 
specified (P = 0.19).
Detection of any virus
Of all demographic characteristics and symptoms and signs collected, 
37 were associated with detection of ≥1 type of virus in univariable 
Table 1. Throat swabs taken by clinician at baseline study visit: methods of microbe identification and prevalence at baseline study visit
Microbe Method of identification Prevalence
n/N (%)
Bacteria
 Staphylocococcus aureus Culture 725/2170 (33.4%)
 Haemophilus influenzae Culture 513/2170 (23.6%)
 Streptococcus pneumoniae Culture 322/2170 (14.8%)
 Group A beta haemolytic Streptococcus Culture 183/2170 (8.4%)
 Mycoplasma pneumoniae qPCR 72/2132 (3.4%)
 Group G beta haemolytic Streptococcus Culture 37/2170 (1.7%)
 Bordetella pertussis qPCR 27/2132 (1.3%)
 Group C beta haemolytic Streptococcus Culture 20/2170 (0.9%)
 Chlamydophilia pneumoniae qPCR 8/2132 (0.4%)
 Bordetella parapertussis qPCR 6/2131 (0.3%)
 Moraxella catarrhalis Culture 5/2170 (0.2%)
 Group F beta haemolytic Streptococcus Culture 0/2170 (0.0%)
Viruses
 Rhinovirus qPCR 272/2152 (12.6%)
 Enterovirus qPCR 139/2132 (6.5%)
 Respiratory syncytial viruses qPCR 129/2181 (5.9%)
 Influenza A qPCR 96/2181 (4.4%)
 Coronavirus qPCR 85/2132 (4.0%)
 Parainfluenzavirus type 3 qPCR 61/2181 (2.8%)
 Metapneumoviruses qPCR 57/2181 (2.6%)
 Bocavirus qPCR 48/2132 (2.3%)
 Influenza B qPCR 48/2181 (2.2%)
 Adenovirus qPCR 41/2179 (1.9%)
 Parainfluenzavirus type 1 qPCR 35/2181 (1.6%)
 Parainfluenzavirus type 4 qPCR 24/2132 (1.1%)
 Parechovirus qPCR 9/2132 (0.4%)
 Parainfluenzavirus type 2 qPCR 5/2181 (0.2%)
qPCR = pathogen identified by quantitative PCR.
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analysis (Supplementary Data Table S3). In multivariable analysis, 6 
variables remained significantly associated with the detection of any 
virus (Table 2). The model showed poor discrimination, with an area 
under the ROC curve of 0.64 [95% CI 0.61–0.66]. Viral detection 
was not associated with clinician-reported diagnosis of viral infec-
tion: in 628 children for whom clinicians reported specific suspi-
cion of viral cause, 42% had RTI-related viruses detected from their 
throat swab, versus 42% with no viral cause specified (P = 0.86).
Detection of individual microbes
Seven of the 26 microbes sought had baseline prevalence ≥5%, 
and were therefore included in analysis: S.  aureus, β-haemolytic 
Streptococcus A, S. pneumoniae, H. influenzae, RSV, enteroviruses and 
rhinoviruses. No variables were associated with detection of S. aureus 
in univariable analysis. Multivariable associations are presented in 
Table  2. Sensitivity and specificity of multivariable models are also 
presented in Table 2 and were essentially poor other than for RSV.
Bordetella pertussis was detected in 1.3% of children. Whilst 
throat swabs are not recommended by Public Health England or 
the Center for Disease Control for pertussis diagnosis, this suggests 
potential for untreated infection in the community which should be 
considered by clinicians and future research.
Antibiotic prescribing and bacterial detection
Antibiotic prescribing rates did not differ between children with 
RTI-related bacteria detected (40.1% prescribed antibiotics) and 
Figure 1. Recruitment flowchart and swab availability: cross-sectional and follow-up studies
4 Family Practice, 2017, Vol. 00, No. 00
Ta
b
le
 2
. 
M
u
lt
iv
ar
ia
b
le
 a
ss
o
ci
at
io
n
s 
b
et
w
ee
n
 s
ym
p
to
m
s,
 s
ig
n
s 
an
d
 d
em
o
g
ra
p
h
ic
 v
ar
ia
b
le
s 
an
d
 m
ic
ro
b
e 
d
et
ec
ti
o
n
V
ar
ia
bl
e
A
dj
us
te
d 
od
ds
 r
at
io
 [
95
%
 c
on
fid
en
ce
 in
te
rv
al
], 
P
 v
al
ue
A
ny
 v
ir
us
A
ny
 b
ac
te
ri
a
β-
ha
em
ol
yt
ic
  
St
re
pt
oc
oc
cu
s 
A
S.
 p
ne
um
on
ia
e
H
. i
nfl
ue
nz
ae
R
SV
E
nt
er
ov
ir
us
es
R
hi
no
vi
ru
se
s
S.
 a
ur
eu
s
A
ge
 <
2 
ye
ar
s
1.
65
  
[1
.3
6–
1.
99
], 
<0
.0
01
—
0.
31
  
[0
.2
0–
0.
50
], 
<0
.0
01
1.
53
  
[1
.1
9–
1.
96
], 
0.
00
1
—
2.
48
  
[1
.6
9–
1.
69
], 
<0
.0
01
—
—
—
B
lo
ck
ed
/ r
un
ny
 n
os
e 
du
ri
ng
 t
he
 la
st
 2
4 
ho
ur
s 
(s
ev
er
e)
—
—
—
—
—
—
—
1.
86
  
[1
.3
2–
2.
63
], 
<0
.0
01
—
B
lo
ck
ed
/ r
un
ny
 n
os
e 
in
 
th
e 
la
st
 2
4 
ho
ur
s
1.
57
  
[1
.2
8–
1.
93
], 
<0
.0
01
—
—
—
1.
56
  
[1
.2
3–
1.
98
], 
<0
.0
01
2.
67
  
[1
.4
0–
1.
40
], 
0.
00
3
—
—
—
C
hi
lls
 in
 t
he
 la
st
 2
4 
ho
ur
s 
(s
ev
er
e)
—
—
—
—
3.
16
 [
1.
55
–6
.4
1]
, 
0.
00
1
—
—
—
—
D
is
tu
rb
ed
 s
le
ep
 d
ur
in
g 
th
e 
ill
ne
ss
—
—
—
1.
64
  
[1
.1
8–
2.
30
], 
0.
00
4
—
—
—
—
—
D
is
tu
rb
ed
 s
le
ep
 in
 t
he
 
la
st
 2
4 
ho
ur
s 
(s
ev
er
e)
1.
52
  
[1
.2
1–
1.
92
], 
<0
.0
01
—
—
—
—
—
—
—
—
D
ry
 c
ou
gh
 in
 t
he
 la
st
 
24
 h
ou
rs
—
—
—
—
1.
4 
 
[1
.1
3–
1.
72
], 
0.
00
2
—
—
—
—
E
at
in
g 
le
ss
 d
ur
in
g 
th
e 
ill
ne
ss
—
—
1.
68
  
[1
.2
0–
2.
37
], 
0.
00
3
—
—
—
—
—
E
at
in
g 
le
ss
 in
 t
he
 la
st
 
24
 h
ou
rs
—
—
—
1.
53
  
[1
.1
9–
1.
98
], 
0.
00
1
—
—
—
—
Fe
ve
r 
du
ri
ng
 t
he
 il
ln
es
s
—
—
—
—
—
—
2.
19
  
[1
.4
6–
3.
28
], 
<0
.0
01
0.
53
  
[0
.4
1–
0.
69
], 
<0
.0
01
—
H
ig
h 
re
sp
ir
at
or
y 
ra
te
 
(a
ge
-a
dj
us
te
d)
—
—
—
0.
51
  
[0
.3
3–
0.
78
], 
0.
00
2
—
—
—
—
—
H
ig
h 
te
m
pe
ra
tu
re
1.
89
  
[1
.4
4–
2.
49
], 
<0
.0
01
—
—
—
—
2.
08
  
[1
.3
1–
3.
31
], 
0.
00
2
—
—
—
Il
ln
es
s 
w
or
se
ne
d 
re
ce
nt
ly
—
—
—
—
1.
41
  
[1
.1
1–
1.
78
], 
0.
00
5
—
—
—
—
IM
D
 s
co
re
0.
99
  
[0
.9
8–
1.
00
], 
0.
00
1
—
—
—
—
—
—
—
—
In
fla
m
ed
 p
ha
ry
nx
—
—
1.
70
  
[1
.2
4–
2.
35
], 
0.
00
1
—
—
—
—
—
—
L
ow
 e
ne
rg
y 
du
ri
ng
 t
he
 
ill
ne
ss
—
1.
34
  
[1
.1
7–
1.
67
, <
0.
00
1
—
—
—
—
—
—
—
N
um
be
r 
of
 c
hi
ld
re
n 
in
 
th
e 
ho
m
e 
>1
—
—
—
—
—
—
0.
51
  
[0
.3
6–
0.
73
], 
<0
.0
01
—
—
Pa
llo
r
1.
34
  
[1
.0
8–
1.
65
], 
0.
00
7
—
0.
62
  
[0
.4
6–
0.
85
], 
0.
00
3
—
—
—
—
—
Pr
od
uc
ti
ve
 c
ou
gh
 d
ur
-
in
g 
th
e 
ill
ne
ss
—
—
—
—
—
1.
85
  
[1
.2
1–
2.
84
], 
0.
00
5
—
—
—
Pr
od
uc
ti
ve
 c
ou
gh
 in
 t
he
 
la
st
 2
4 
ho
ur
s 
(s
ev
er
e)
—
—
—
—
1.
63
  
[1
.1
6–
2.
29
], 
0.
00
5
—
—
—
—
Clinical presentation of respiratory tract infection: association with throat swab microbiological results 5
children without RTI-related bacterial detection (40.9% prescribed 
antibiotics, P = 0.72).
Follow-up study
Population characteristics
Gender, age, mother’s smoking status, index of multiple depriva-
tion score and number of children in the home were comparable 
in follow-up study recruits and the rest of the cohort. However, 
follow-up study recruits were more likely to have been breastfed at 
three months (75% versus 46%), have older mothers (median age: 
36 years versus 33 years) and children in the white ethnic group were 
less prevalent (78% versus 88%).
Microbe detection
Detection rates of ≥1 type of RTI-related microbe were higher at 
symptomatic baseline consultations than asymptomatic follow-up 
visits. Difference was more marked for RTI-related viruses (68% 
versus 26%, P < 0.001) than RTI-related bacteria (56% versus 40%, 
P = 0.01). Analysis of individual microbe prevalence at baseline and 
follow-up was limited to 10 microbes that were detected at >5% at 
the baseline visit in this population (Table 3). Detection of H. influ-
enzae and rhinovirus was higher at baseline than follow-up (16% 
versus 0%, P < 0.001 and 19% versus 1%, P < 0.001, respectively). 
S.  aureus, coronavirus and enterovirus showed little difference in 
detection between baseline and follow-up (≤2%, P = 0.71, 1.00 and 
1.00, respectively). Differences between baseline and follow-up rates 
were observed for S.  pneumoniae, influenza B, RSV, β-haemolytic 
streptococcus A and influenza A, which approached but did not meet 
the strict criteria for significance of P ≤ 0.005.
Discussion
Summary of principal findings
Our analysis found no evidence that clinical presentation is associ-
ated with the detection of one or more RTI-related bacteria, and lit-
tle evidence that clinical presentation is associated with the detection 
of one or more RTI-related viruses, in children presenting to primary 
care with RTI. Clinical presentation was not sufficiently sensitive or 
specific to predict detection of individual microbes from the throat, 
with the exception of RSV, which showed reasonable association 
with four symptoms and signs (blocked nose, high temperature, pro-
ductive cough and shortness of breath) and two temporal factors 
(age <2  years and recruitment in the months of October-March). 
Our small follow-up study showed that overall, microbe detection 
was more common in children when they were unwell with RTI than 
when they had recovered, especially with regard to rhinovirus, RSV, 
H. influenzae and S. pneumoniae. There was little or no change in 
prevalence of enteroviruses, coronaviruses and S. aureus, suggesting 
that they may be commensal or causing subclinical infection in this 
population.
Strengths and weaknesses of the study
To our knowledge, this is the first study to examine associations 
between clinical presentation and a wide range of RTI-related bacte-
ria and viruses in a primary care paediatric population. Participants 
were broadly representative of local population in gender, ethnic-
ity, deprivation scores and maternal age. Laboratory methods were 
standardised to ensure consistent results. Children recruited to the 
follow-up study were broadly representative of the larger study 
population. The repeated-measures design of the follow-up study, V
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along with recruitment of children who did not receive antibiotics, 
removed as far as possible any confounding effects of factors such as 
children’s age, siblings, daycare attendance, household deprivation 
(14) and antimicrobial prescribing on microbe detection.
These analyses should be regarded as exploratory; their 
multiplicity increases the risk of Type I  error. We used adjusted 
p-values to reduce this risk, but if we were too stringent in this, 
we may have introduced Type II errors. Specific prior hypotheses 
regarding the associations explored would have helped target the 
analysis, but the absence of prior evidence in this area meant that 
this was necessarily an exploratory study. Additionally, the sam-
ple size of the follow-up study was not large enough to detect 
whether what appeared to be important variation in detection 
was in fact due to chance, and the low response rate may have led 
to a biased sample.
In the absence of a gold standard single sample site from the 
upper respiratory tract, we took a pragmatic decision to use throat 
swabs for microbial detection as we judged them to be the sampling 
method most acceptable to parents and busy primary care clinicians. 
We acknowledge that, although we might have achieved significantly 
lower sampling rates, samples obtained and pooled from the oro-
pharynx, nasopharynx and nares could have mitigated the known 
problem of different optimal sample sites for different microbes (15) 
and might have produced more sensitive and specific results for some 
microbes.
Additionally, to obtain samples which might be diagnostic of 
lower respiratory tract infections, sampling from the lower respira-
tory tract would be desirable. However, unless non-invasive alter-
natives to bronchoscopy and transthoracic pulmonary aspiration 
become available, sampling from the upper respiratory tract remains 
the only option to obtain a microbiological respiratory sample in 
primary care.
This study attempted to examine only 26 microorganisms out 
of hundreds that exist in the upper respiratory tract; important can-
didates may have been missed. We have not explored the clinical 
impact of co-detection or microbial density or load in this paper, but 
this is planned in future work.
Results in the context of other studies
Previous work seeking associations between microbe detection and 
clinical presentation has mostly been conducted in secondary care 
(hospital settings). A previous systematic review searched primary and 
secondary care literature for the association of microbe detection with 
symptoms and signs in children and found a broad absence of evidence 
in this area (10). Regarding the follow-up study, Rhedin et  al. pub-
lished a case-control study in 2014 which compared viral detection 
rates in nasopharyngeal aspirates from 225 children attending emer-
gency departments in Sweden with and without symptoms of RTI (16). 
Despite differences in study design, population and country, of note is 
the agreement of the follow-up study findings of a small/no relative 
decrease between the prevalence of enterovirus and coronavirus in chil-
dren with and without RTI. Marked decreases in rhinovirus and RSV 
prevalence were also replicated. Additionally, decreases in rhinovirus 
and RSV detection were observed by Regamey et al. in a 2008 study 
of nasal swabs from 128 children during and after RTI (17). However, 
this study also reported a pronounced fall in coronavirus detection, in 
contrast to our follow-up study results, perhaps reflecting differences in 
coronavirus strains circulating in this population.
Meaning of the study: possible explanations and 
implications for clinicians and policymakers
A 2007 Health Technology Assessment report discusses the use 
of validation in evaluating a diagnostic test in the absence of ‘an 
unproblematic and equivocal reference standard’. (18) The associa-
tions demonstrated here between clinical presentation and upper 
respiratory tract microbes provide little evidence to suggest that 
some microbes detected from the upper respiratory tract using 
throat swabs may be aetiologically related to acute RTI and cough. 
This evidence in isolation is not sufficient, but should be considered 
alongside evidence from future studies (18).
We have considered two possible interpretations regarding the fall 
in prevalence of microbes between the symptomatic and asymptomatic 
assessments. The first is that the microbes are causally linked to the 
symptoms. A second explanation is that the inflammatory process in 
Table 3: Detection of individual RTI-related bacteria and viruses in baseline (RTI) and follow-up (non-RTI) samples
Microbe % samples with virus detected Decrease in detection between  
RTI and non-RTI visits
P value n (% data missing)
Baseline (RTI) Follow-up  
(non-RTI)
Absolute Relative
Viruses
 Rhinovirus 15 (19%) 1 (1%) 14% 93% <0.001*† 78 (1%)
 RSV 6 (8%) 0 (0%) 6% 100% 0.031† 78 (1%)
 Influenza B 5 (5%) 0 (0%) 5% 100% 0.13† 78 (1%)
 Influenza A 5 (6%) 1 (1%) 4% 80% 0.219† 78 (1%)
 Coronaviruses 4 (5%) 3 (4%) 1% 25% 1.00† 74 (6%)
 Enterovirus 4 (5%) 4 (5%) 0% 0% 1.00 74 (6%)
Bacteria
 H. influenzae 13 (16%) 0 (0%) 16% 100% <0.001* 79 (0%)
 S. pneumoniae 11 (14%) 2 (3%) 12% 82% 0.023† 79 (0%)
 Β-haemolytic strep A 8 (10%) 2 (3%) 8% 75% 0.070† 79 (0%)
 S. aureus 26 (33%) 24 (30%) 3% 8% 0.71 79 (0%)
Median time elapsed between baseline (RTI) and follow-up (non-RTI) swabs: 22 days (interquartile range 14–30 days).
*Indicates a P value <0.005.
†Cell value expected <5; McNemar’s exact test used.
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the upper respiratory tract allows some microbes to proliferate, mak-
ing their detection more likely when children are symptomatic (19,20).
These results are in line with commonly-held views that rhino-
virus is associated with mild, non-febrile cold symptoms. They also 
demonstrate that β-haemolytic Streptococcus A infection is uncom-
mon in children aged <2 years.
Conclusion
The need for a significant reduction in the amount of antibiotics pre-
scribed for RTI in primary care is recognised globally. Definition of a 
microbiological diagnosis is one of several approaches which, together 
with research into identifying patients with poor prognostic outcome, 
improving patient education and improving consultation skills, can 
tackle the problem. We have demonstrated that, currently, antibiotic 
prescribing is not targeted to children in whom RTI-related bacteria 
are detected from the throat during RTI, leaving the question of the 
effect of targeted antibiotic prescribing unanswered in this group.
Advances in microbiological technology mean that point of care 
testing of biological samples for the diagnosis of primary care RTI 
could soon become a reality. In this study, H. influenzae, S. pneumo-
niae, Β-haemolytic streptococcus A and RSV decreased in prevalence 
between baseline and follow-up, making them potential candidates to 
consider in future work exploring point of care tests in this population.
Supplementary Data
Supplementary data are available at Family Practice online.
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